Cargando…

CD93 in macrophages: A novel target for atherosclerotic plaque imaging?

Noninvasive imaging atherosclerotic (AS) plaque is of great importance for early diagnosis. Recently, CD93 in MΦ was linked to atherosclerosis development. Herein, we have investigated whether CD93 in MΦ is a potential novel target for atherosclerotic plaque imaging. CD93(hi) and CD93(lo) MΦ were pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chen, Han, Yeming, Qu, Bin, Zhang, Chao, Liang, Ting, Gao, Feng, Hou, Guihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995462/
https://www.ncbi.nlm.nih.gov/pubmed/35166040
http://dx.doi.org/10.1111/jcmm.17237
_version_ 1784684302616756224
author Su, Chen
Han, Yeming
Qu, Bin
Zhang, Chao
Liang, Ting
Gao, Feng
Hou, Guihua
author_facet Su, Chen
Han, Yeming
Qu, Bin
Zhang, Chao
Liang, Ting
Gao, Feng
Hou, Guihua
author_sort Su, Chen
collection PubMed
description Noninvasive imaging atherosclerotic (AS) plaque is of great importance for early diagnosis. Recently, CD93 in MΦ was linked to atherosclerosis development. Herein, we have investigated whether CD93 in MΦ is a potential novel target for atherosclerotic plaque imaging. CD93(hi) and CD93(lo) MΦ were prepared with or without LPS stimulation, before biological activity was evaluated. A rat AS model was produced with left carotid artery clamped. Whole‐body/ex vivo phosphor autoradiography of the artery and biodistribution were investigated after incorporation of (3)H‐2‐DG into CD93(hi) and CD93(lo) MΦ or after (125)I‐α‐CD93 ((125)I‐anti‐CD93mAb) injection. The plaque tissue was subjected to CD93/CD68 immunofluorescence/immunohistochemistry staining. CD93(hi) and CD93(lo) MΦ cells were successfully prepared without significant effect on bioactivity after incorporative labelled with (3)H‐2‐DG. The AS model was successfully established. Biodistribution studies showed that adoptive transfer of (3)H‐2‐DG‐CD93(hi) MΦ or (125)I‐ α‐CD93 injection resulted in accumulation of radioactivity within the atherosclerotic plaque in the clamped left carotid artery. T/NT (target/non‐target, left/right carotid artery) ratio was higher in the (3)H‐2‐DG‐CD93(hi) MΦ adoptive transfer group than in the (3)H‐2‐DG‐CD93(lo) MΦ group (p < .05). Plaque radioactivity in the (125)I‐α‐CD93 injection group was significantly higher than in the (125)I‐IgG control group (p < .01). The higher radioactivity accumulated in the clamped left carotid artery was confirmed by phosphor autoradiography. More importantly, CD93/CD68 double‐positive MΦ accumulated at the atherosclerotic plaque in (3)H‐2‐DG‐CD93(hi) MΦ adoptive transfer group, which correlated with plaque radioactivity (r = .99, p < .01). In summary, both adoptive‐transferred (3)H‐2‐DG‐labelled CD93(hi) MΦ and (125)I‐α‐CD93 injection specifically targeted CD93 in atherosclerotic plaque. CD93 is a potential target in atherosclerotic plaque imaging.
format Online
Article
Text
id pubmed-8995462
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89954622022-04-15 CD93 in macrophages: A novel target for atherosclerotic plaque imaging? Su, Chen Han, Yeming Qu, Bin Zhang, Chao Liang, Ting Gao, Feng Hou, Guihua J Cell Mol Med Original Articles Noninvasive imaging atherosclerotic (AS) plaque is of great importance for early diagnosis. Recently, CD93 in MΦ was linked to atherosclerosis development. Herein, we have investigated whether CD93 in MΦ is a potential novel target for atherosclerotic plaque imaging. CD93(hi) and CD93(lo) MΦ were prepared with or without LPS stimulation, before biological activity was evaluated. A rat AS model was produced with left carotid artery clamped. Whole‐body/ex vivo phosphor autoradiography of the artery and biodistribution were investigated after incorporation of (3)H‐2‐DG into CD93(hi) and CD93(lo) MΦ or after (125)I‐α‐CD93 ((125)I‐anti‐CD93mAb) injection. The plaque tissue was subjected to CD93/CD68 immunofluorescence/immunohistochemistry staining. CD93(hi) and CD93(lo) MΦ cells were successfully prepared without significant effect on bioactivity after incorporative labelled with (3)H‐2‐DG. The AS model was successfully established. Biodistribution studies showed that adoptive transfer of (3)H‐2‐DG‐CD93(hi) MΦ or (125)I‐ α‐CD93 injection resulted in accumulation of radioactivity within the atherosclerotic plaque in the clamped left carotid artery. T/NT (target/non‐target, left/right carotid artery) ratio was higher in the (3)H‐2‐DG‐CD93(hi) MΦ adoptive transfer group than in the (3)H‐2‐DG‐CD93(lo) MΦ group (p < .05). Plaque radioactivity in the (125)I‐α‐CD93 injection group was significantly higher than in the (125)I‐IgG control group (p < .01). The higher radioactivity accumulated in the clamped left carotid artery was confirmed by phosphor autoradiography. More importantly, CD93/CD68 double‐positive MΦ accumulated at the atherosclerotic plaque in (3)H‐2‐DG‐CD93(hi) MΦ adoptive transfer group, which correlated with plaque radioactivity (r = .99, p < .01). In summary, both adoptive‐transferred (3)H‐2‐DG‐labelled CD93(hi) MΦ and (125)I‐α‐CD93 injection specifically targeted CD93 in atherosclerotic plaque. CD93 is a potential target in atherosclerotic plaque imaging. John Wiley and Sons Inc. 2022-02-15 2022-04 /pmc/articles/PMC8995462/ /pubmed/35166040 http://dx.doi.org/10.1111/jcmm.17237 Text en © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Su, Chen
Han, Yeming
Qu, Bin
Zhang, Chao
Liang, Ting
Gao, Feng
Hou, Guihua
CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title_full CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title_fullStr CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title_full_unstemmed CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title_short CD93 in macrophages: A novel target for atherosclerotic plaque imaging?
title_sort cd93 in macrophages: a novel target for atherosclerotic plaque imaging?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995462/
https://www.ncbi.nlm.nih.gov/pubmed/35166040
http://dx.doi.org/10.1111/jcmm.17237
work_keys_str_mv AT suchen cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT hanyeming cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT qubin cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT zhangchao cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT liangting cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT gaofeng cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging
AT houguihua cd93inmacrophagesanoveltargetforatheroscleroticplaqueimaging